Related Articles
Limited correlation between tumor markers and minimal residual disease detected by seven neuroblastoma‑associated mRNAs in high‑risk neuroblastoma patients
How to detect the rare BCR‑ABL (e14a3) transcript: A case report and literature review
Higher levels of minimal residual disease in peripheral blood than bone marrow before 1st and 2nd relapse/regrowth in a patient with high‑risk neuroblastoma: A case report
ND‑09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR‑ABL signaling Corrigendum in /10.3892/or.2023.8518
Differential expression of minimal residual disease markers in peripheral blood and bone marrow samples from high-risk neuroblastoma patients